HST Global To Establish New Clinical Treatment Facility In Costa Rica

HST Global said that with Benson’s assistance, it plans to license the ‘FIT’ protocol, as well as other pending protocols, to clinical treatment facilities in both Panama and Costa Rica.

Ron Howell, president and CEO of HST Global, said: “Greg and his team are familiar with the demographic peculiarities, economic conditions and political climate of Panama and Costa Rica.

“Through this strategic partnership, we will be able to utilise his knowledge as well as leverage and align our resources in an effort to develop our Panamanian and Costa Rican Treatment Facilities.”

Mr Benson said: “Ron and his team at HST Global are dedicated to bringing humanity alternative treatments for life threatening illnesses, specifically late stage cancer. HST Global is relying on international markets to gain a universal footprint and reach a worldwide audience.

“During communications with HST, it became apparent there were synergies between our companies that could be employed to develop Clinical Treatment Facilities in both Panama and Costa Rica.”

HST Global is an integrated biotechnology health and wellness company that is developing and or acquiring a network of wellness centers worldwide that are primarily focused on the immunotherapy and alternative treatment of late stage cancer.

In addition, HST Global intends to acquire products for the treatment of late stage cancer. In this regard, the company primarily focuses on immunotherapy and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer.